Jeroen Dekervel

KU Leuven — Belgium

Medicine · Health Sciences

23h-index3.2kcitations168works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(30), Cancer, Hypoxia, and Metabolism(24), Cholangiocarcinoma and Gallbladder Cancer Studies(20), RNA modifications and cancer(19), Pancreatic and Hepatic Oncology Research(18)

Publications165 total

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
Targeted Oncology·2026
Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: Insights from 25-years of real-world data.
Journal of Clinical Oncology·2026
DOP126 ECCO Topical Review on IBD-like patterns of drug colitis with practical guidance and a focus on immune checkpoint inhibitors
Journal of Crohn s and Colitis·2026Open Access
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges
Cancers·2025· 1 citedOpen Access
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors
Pharmaceuticals·2025Open Access
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab
European Journal of Cancer·2025
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment
Cell Reports Medicine·2025· 2 citedOpen Access
TREM2 macrophages are associated with enhanced response to PD-1 blockade in human hepatocellular carcinoma
2025Open Access
99TiP SAFIR ABC10: Targeted maintenance therapy versus first-line standard of care in advanced biliary cancer
Annals of Oncology·2025
2099P Trastuzumab deruxtecan (T-DXd) vs ramucirumab (RAM) plus paclitaxel (PTX) in second-line (2L) treatment of patients (pts) with HER2+ unresectable/metastatic gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): Additional data from DESTINY-Gastric04 (DG-04)
Annals of Oncology·2025
ESMO podcast on upper gastrointestinal cancers—highlights in esophagogastric cancers from ASCO 2025
ESMO Gastrointestinal Oncology·2025Open Access
Controversies in upper gastrointestinal cancers—the role of radiotherapy in borderline resectable pancreatic cancer
ESMO Gastrointestinal Oncology·2025Open Access
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
Oncology·2025· 2 cited
ESMO Podcast on upper gastrointestinal cancers—highlights in biliary and pancreatic cancers from ASCO 2025
ESMO Gastrointestinal Oncology·2025Open Access
209. POSTOPERATIVE MORBIDITY AND LONG-TERM SURVIVAL AFTER ESOPHAGECTOMY FOR CANCER IS NOT INFLUENCED BY GENDER: A PROPENSITY-SCORE MATCHED ANALYSIS
Diseases of the Esophagus·2025
Role of FAPI PET/CT in cancer of unknown primary (CUP): A systematic review
European Journal of Radiology·2025· 3 cited
Negative impact of corticosteroid use on outcome in patients with advanced <scp>BTCs</scp> treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population
International Journal of Cancer·2025Open Access
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population
JNCI Journal of the National Cancer Institute·2025· 1 citedOpen Access
211P Retrospective analysis of liver transplantation eligibility based on the Milan criteria in patients with gastroenteropancreatic neuroendocrine tumors
Annals of Oncology·2025Open Access
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The <scp>MAGIC</scp>‐D Index
Liver International·2025· 4 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Eric Van Cutsem(32), Chris Verslype(32), Jos van Pelt(13), Christophe M. Deroose(12), Diether Lambrechts(8), Hannah van Malenstein(6), Elin Pauwels(6), Frederik Cleeren(6), Vincent Vandecaveye(6), Josep Tabernero(5), Frederik Nevens(5), Sarah Cappuyns(5), Michel Koole(5), Koen Van Laere(5), Guy Bormans(5), Annouschka Laenen(5), Karen Geboes(5), Ashenafi Bulle(5), Petra Windmolders(4), Hans Prenen(4)